Work

Initial Results of a Phase I Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Relapsed/Refractory Multiple Myeloma

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-139893

Authors: Cesar Rodriguez, Anita D'Souza, Nina Shah, Peter M. Voorhees, Ben Buelow, Ravi Vij, Shaji K. Kumar

Institutions: Wake Forest University Health Sciences, Wake Forest University, Medical College of Wisconsin, University of California, San Francisco, Levine Cancer Institute, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097414305

FWCI: 6.808

Cites:

Cited by: 52

Related to: 10